跳至主要内容
临床试验/NCT03607071
NCT03607071已完成2 期

Outcome of Myocardial Inflammation After Steroid Therapy in Thai Systemic Sclerosis Patients: an Open Label Study

Khon Kaen University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年5月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Changing of degree of myocarditis evaluated by cardiac MRI after treatment compare to baseline

研究概览

简要总结

Primary myocardial involvement is common in scleroderma, effected to pericardium, vascular, conducting defect and especially myocardium. Cardiac MRI is widely used for assessment of cardiac involvement in scleroderma, both structural and functional pathology. Cardiac MRI has a diagnostic accuracy of 85% for the detection of myocardial inflammation. Nowadays, the treatment of myocardial inflammation in scleroderma is uncertain. The investigator's study aims to define the cardiac outcome after moderate dose steroid therapy in the patients who have myocardial inflammation detection by cardiac MRI.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The adult scleroderma patients who were defined as having myocardial inflammation by cardiac MRI.

排除标准

  • Current infection that needs systemic antibiotic therapy
  • Active viral hepatitis B or C
  • Uncontrolled diabetes mellitus

研究组 & 干预措施

Prednisolone

Experimental

The patient who has detected myocardial inflammation from cardiac MRI from baseline is given prednisolone 30 mg/d and taper 5-10 mg per 2 weeks until off at week 24.

干预措施: Prednisolone and taper (Drug)

结局指标

主要结局

Changing of degree of myocarditis evaluated by cardiac MRI after treatment compare to baseline

时间窗: 24 weeks

Myocarditis is defined as inflammatory disease of the myocardium according to the cardiac MRI Lake Louise criteria at least 2 of the following criteria: 1. Regional or global myocardial signal intensity increased in the T2-weighted images; 2. Increased global myocardial early enhancement ratio between the myocardium and skeletal muscle in the gadolinium-enhanced T1-weighted images; and, 3. At least 1 focal lesion with nonischemic regional distribution in the inversion-recovery-prepared, gadolinium-enhanced, T1-weighted images (delayed enhancement). Response to treatment is defined as any reducing of degree of myocarditis without any progression of myocardial fibrosis or scarring when compared to the cardiac MRI baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chingching Foocharoen

Principle investigator

Khon Kaen University

研究点 (1)

Loading locations...

相似试验